MYGN: Summary for Myriad Genetics, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:28am EST - Canadian Markets open in 3 hours and 2 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Myriad Genetics Inc. (MYGN)

On Feb 9: 21.45 USD 0.00 (0.00%)

MORE ON MYGN

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Myriad Genetics, Inc. (NasdaqNM:MYGN) Delayed quote data

Last Trade:	21.45 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	21.45
Open:	N/A
Bid:	N/A
Ask:	24.99 x 100
1y Target Est:	58.43

Day's Range:	N/A - N/A
52wk Range:	21.27 - 47.08
Volume:	0
Avg Vol (3m):	1,659,020
Market Cap:	2.06B
P/E (ttm):	N/A
EPS (ttm):	-0.73
Div & Yield:	3.50 (16.32%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add MYGN to Portfolio

Download Data

HEADLINES

•	Biotech ETFs Immune To Broad Selling
	Investor's Business Daily (Mon, Feb 8)

•	MYRIAD GENETICS INC Financials
	EDGAR Online Financials (Sat, Feb 6)

•	My Favorite Investor
	at Motley Fool (Thu, Feb 4)

•	4-Star Stocks Poised to Pop: Myriad Genetics
	at Motley Fool (Thu, Feb 4)

•	Biotech Stocks: Pfizer leads drug stocks south
	at MarketWatch (Wed, Feb 3)

•	New Star Analyst Rankings for Myriad Genetics, Inc.
	StarMine (Wed, Feb 3)

•	Myriad Surpasses Zacks Estimate
	Zacks.com (Wed, Feb 3)

•	MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Wed, Feb 3)

•	Myriad Genetics Inc. F2Q10 Earnings Conference Call
	at Seeking Alpha (Tue, Feb 2)

•	Judge hears arguments over rights to gene patents
	AP (Tue, Feb 2)

•	Myriad Genetics 2Q profit rises 67 percent
	AP (Tue, Feb 2)

More Headlines for MYGN...

ANALYST

EPS Est (next year) (Jun-08) :	N/A
EPS Est (in 2 years) (Jun-09) :	N/A
Avg Rec (current)*:	2.3
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Myriad Genetics, Inc., a biotechnology company, engages in the development and marketing of therapeutic and molecular diagnostic products. The company offers molecular diagnostic products comprising BRACAnalysis for assessing a woman's risk for br...

Full Company Profile

Add to Portfolio

Email to a Friend

•